Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.85 USD
+0.15 (0.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $44.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for Bristol Myers Squibb Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 12,280 | 9,253 | 16,966 | 15,831 | 15,393 |
Receivables | 10,921 | 9,886 | 9,369 | 8,501 | 7,685 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,662 | 2,339 | 2,095 | 2,074 | 4,293 |
Other Current Assets | 5,907 | 5,795 | 4,832 | 3,786 | 1,983 |
Total Current Assets | 31,770 | 27,273 | 33,262 | 30,192 | 29,354 |
Net Property & Equipment | 6,646 | 6,255 | 6,049 | 5,886 | 6,252 |
Investments & Advances | 364 | 0 | 0 | 433 | 767 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2,768 | 1,344 | 1,439 | 1,161 | 510 |
Intangibles | 48,241 | 57,008 | 63,029 | 73,790 | 86,457 |
Deposits & Other Assets | 5,370 | 4,940 | 5,535 | 7,019 | 6,604 |
Total Assets | 95,159 | 96,820 | 109,314 | 118,481 | 129,944 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3,259 | 3,040 | 2,949 | 2,713 | 2,445 |
Current Portion Long-Term Debt | 3,119 | 4,264 | 4,948 | 2,340 | 3,346 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15,884 | 14,586 | 13,971 | 14,027 | 12,513 |
Total Current Liabilities | 22,262 | 21,890 | 21,868 | 19,080 | 18,304 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 338 | 2,166 | 4,501 | 5,407 | 6,454 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 36,653 | 35,056 | 39,605 | 48,336 | 43,387 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 6,421 | 6,590 | 7,334 | 7,776 | 10,101 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 65,674 | 65,702 | 73,308 | 80,599 | 78,246 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 292 | 292 | 292 | 292 | 292 |
Capital Surplus | 45,684 | 45,165 | 44,361 | 44,325 | 43,709 |
Retained Earnings | 28,766 | 25,503 | 23,820 | 21,281 | 34,474 |
Other Equity | -1,491 | -1,224 | -1,208 | -1,779 | -1,420 |
Treasury Stock | 43,766 | 38,618 | 31,259 | 26,237 | 25,357 |
Total Shareholder's Equity | 29,485 | 31,118 | 36,006 | 37,882 | 51,698 |
Total Liabilities & Shareholder's Equity | 95,159 | 96,820 | 109,314 | 118,481 | 129,944 |
Total Common Equity | 29,485 | 31,118 | 36,006 | 37,882 | 51,698 |
Shares Outstanding | 2,034.70 | 2,126.10 | 2,219.60 | 2,262.60 | 2,228.00 |
Book Value Per Share | 14.49 | 14.64 | 16.22 | 16.74 | 23.20 |
Fiscal Year End for Bristol Myers Squibb Company falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 12,280 | 7,685 | 8,730 | 9,269 |
Receivables | NA | 10,921 | 10,304 | 10,112 | 10,054 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 2,662 | 2,436 | 2,364 | 2,605 |
Other Current Assets | NA | 5,907 | 7,207 | 6,868 | 5,158 |
Total Current Assets | NA | 31,770 | 27,632 | 28,074 | 27,086 |
Net Property & Equipment | NA | 6,646 | 6,481 | 6,355 | 6,279 |
Investments & Advances | NA | 364 | 325 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 2,768 | 1,514 | 1,572 | 1,317 |
Intangibles | NA | 48,241 | 50,097 | 52,466 | 54,731 |
Deposits & Other Assets | NA | 5,370 | 5,214 | 5,022 | 4,868 |
Total Assets | NA | 95,159 | 91,263 | 93,489 | 94,281 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 3,259 | 2,813 | 3,069 | 3,194 |
Current Portion Long-Term Debt | NA | 3,119 | 5,467 | 3,020 | 2,752 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 15,884 | 15,182 | 14,061 | 13,139 |
Total Current Liabilities | NA | 22,262 | 23,462 | 20,150 | 19,085 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 338 | 399 | 751 | 1,568 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 36,653 | 32,137 | 34,656 | 35,078 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 6,203 | 5,902 | 6,664 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 65,674 | 62,201 | 61,459 | 62,395 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 292 | 292 | 292 | 292 |
Capital Surplus | NA | 45,684 | 44,849 | 45,299 | 45,140 |
Retained Earnings | NA | 28,766 | 28,218 | 27,449 | 26,568 |
Other Equity | NA | -1,491 | -1,222 | -1,330 | -1,306 |
Treasury Stock | NA | 43,766 | 43,075 | 39,680 | 38,808 |
Total Shareholder's Equity | NA | 29,485 | 29,062 | 32,030 | 31,886 |
Total Liabilities & Shareholder's Equity | NA | 95,159 | 91,263 | 93,489 | 94,281 |
Total Common Equity | 0 | 29,485 | 29,062 | 32,030 | 31,886 |
Shares Outstanding | 2,026.70 | 2,034.70 | 2,034.70 | 2,089.10 | 2,100.80 |
Book Value Per Share | 0.00 | 14.49 | 14.28 | 15.33 | 15.18 |